The GSAS Harvard Biotech Club and Morrison & Foerster course on Legal Topics for Scientists, Entrepreneurs, and Start Ups features a combination of lectures and interactive workshops and is designed for students, post-docs, entrepreneurs, and investors with life sciences and tech backgrounds to learn more about:
- Intellectual Property law, including patent prosecution, litigation, trademarks, licensing, and commercial transactions
- Business law, including raising funds, and company exit strategies
- Regulatory law, including the FDA, privacy, and data security
The course will arm attendees with the knowledge scientists, engineers, entrepreneurs, and investors need to manage the legal aspects for launching and growing a startup including how to avoid common mistakes that can have serious consequences down the road. Come learn from seasoned patent, corporate, privacy, licensing, and trademarks lawyers as well as IP litigators at Morrison & Foerster LLP, who counsel cutting-edge companies at all stages of growth.
All sessions are moderated by Michael R. Ward, Ph.D., J.D., global head of the firm’s Life Sciences Practice Group, head of the firm’s Patent Practice Group, co-chair of the firm’s Intellectual Property Practice Group and co-chair of our global Food + Agriculture practice.
Session 1 – IP and Corporate Due Diligence for Investors and Start-Ups
Instructed by: Anita Choi, M.B.A., J.D., Andrew Boyd, LL.B., L.P.C., and Alfredo Silva, J.D.
Session 2 – Commercial Life Sciences Transactions and Licensing issues in a COVID-19 and post-COVID-19 world
Instructed by: Matthew Karlyn, J.D.
Session 3 – Raising Angel Investment
Instructed by: Jim Krenn, J.D.
Session 4 – COVID-19: FDA and Compliance issues with testing, vaccines and therapies
Instructed by: Bethany Hills, J.D.
Session 5 – Considerations for ANDA and BPCIA Litigation
Instructed by: Matthew A. Chivvis, J.D.
Session 6 – PCT application process and international patent prosecution
Instructed by: James J. Mullen, Ph.D., J.D.
Apply for the course
Michael R. Ward
Michael R. Ward is global head of the firm’s Life Sciences Practice Group, head of the firm’s Patent Practice Group, co-chair of the firm’s Intellectual Property Practice Group and co-chair of our global AgTech + Food Industry practice.
Dr. Ward is widely recognized as one of the world’s leading agriculture IP lawyers. As the founder and head of the firm’s Plant Intellectual Property Group, Dr. More ›
Anita Choi’s practice focuses on patent prosecution, portfolio management, IP due diligence, and IP litigation support. Her clients range from early-stage start-up enterprises to established domestic and international companies. She is well-versed in building and managing worldwide patent portfolios across many sectors and technologies, including small-molecule pharmaceuticals, medical devices, diagnostics, industrial chemicals and advanced materials, food and agtech.
Anita’s clients praise her ability to More ›
Andrew Boyd is a M&A partner based in the London office. He specialises in advising on strategic cross-border mergers and acquisitions, private equity and joint venture transactions with particular expertise advising clients in the technology sector.
Andrew regularly represents, among other clients, Visa, SoftBank, Tate & Lyle plc, Unity Technologies, Toshiba and SoundCloud.
Andrew is recommended for M&A and private equity by legal directories including Legal More ›
Alfredo B. D. Silva
Alfredo Silva is a partner in the Corporate Group, is co-chair of the Social Enterprise and Impact Investing Group, and a member of the Pro Bono Committee. Alfredo represents companies and investors in a broad range of corporate and securities law matters, with a focus on businesses in the life sciences, agtech and fintech sectors. Alfredo’s practice includes capital markets transactions, venture capital, growth More ›
Matthew A. Karlyn has 23 years of experience in working with companies in the healthcare, pharmaceutical, medical device, and technology industries on a wide range of commercial life sciences, licensing, and technology transactions. His clients range from Fortune 100 companies to start-ups, and he regularly advises companies on matters involving IP commercialization, complex collaboration transactions, licensing initiatives, subscription-based economics, and business transactions related to More ›
Jim has extensive experience representing private and public companies and investors in significant business transactions from formation through liquidity. His practice focuses on mergers and acquisitions, venture capital financings, and emerging company counseling. His clients span a broad range of industries, including biopharmaceutical, artificial intelligence, medical device, e-commerce, cybersecurity, software, Internet, social media, semiconductor, unmanned vehicles, AgTech, consumer products, finance, Cleantech, and energy.
Jim advises More ›
Bethany J. Hills
Bethany advises her life sciences business clients on both pre- and post-market issues, including everything from FDA submissions and communications strategies to post-approval compliance and reimbursement issues. Her clients include medical device, drug, combination product, diagnostic, biologic, and regenerative medicine, cosmetic, dietary supplement, and food industry companies, and the investor groups focusing on these industries.
Bethany leverages her deep FDA regulatory experience and exceptional knowledge More ›
Matthew A. Chivvis
Matthew protects his life sciences and high-tech clients’ intellectual property and defends his clients wrongly accused of infringement. His hearing and trial experience is extensive. Although his practice focuses on intellectual property litigation in federal and state courts, he also regularly advises clients on plant and agriculture intellectual property matters, including strategic use of plant patents, plant-variety protection certificates, and trademark rights. Matthew also More ›
James J. Mullen III
James combines his scientific experience with his legal training in his practice to craft commercially relevant solutions for his clients’ intellectual property challenges. He is the founder and head of MoFo’s Antibody Patent Group and leads the Patent Group in the San Diego office.
As a patent prosecutor, James is well versed in obtaining focused patent protection that provides a commercial advantage in the marketplace. More ›